Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zicheng Huang

Showing results (51-60 of 68) with videos related to

Pageof 7
Sort By:
Molecular Cancer|August 29, 2014
Malignancy-associated metabolic profiling of human glioma cell lines using 1H NMR spectroscopyWei Shao, Jinping Gu, Caihua Huang, et al.
Journal of Translational Medicine|June 26, 2024
Intestinal mRNA expression profiles associated with mucosal healing in ustekinumab-treated Crohn's disease patients: bioinformatics analysis and prospective cohort validationQing Li, Zicheng Huang, Hongsheng Yang, et al.
Nutrition in Clinical Practice : Official Publication of the American Society for Parenteral and Enteral Nutrition|July 10, 2021
Twelve-week peptide-based formula therapy may be effective in inducing remission of active Crohn disease among women who are pregnant or preparing for pregnancyQingfan Yang, Jian Tang, Ni Ding, et al.
Cell Death & Disease|December 20, 2024
PI(4,5)P2 alleviates colitis by inhibiting intestinal epithelial cell pyroptosis through NNMT-mediated RBP4 m6A modificationQingfan Yang, Na Diao, Fei Ma, et al.
Journal of Nanobiotechnology|October 4, 2023
Exploring the translational potential of PLGA nanoparticles for intra-articular rapamycin delivery in osteoarthritis therapyJian-Chao Ma, Tingting Luo, Binyang Feng, et al.
Oncology Letters|October 23, 2020
Endothelial transdifferentiation of human HGC-27 gastric cancer cells <i>in vitro</i>Changxin Chen, Zhixin Hunag, Mucheng Wang, et al.
Inflammatory Bowel Diseases|August 10, 2024
Developing a Machine-Learning Prediction Model for Infliximab Response in Crohn's Disease: Integrating Clinical Characteristics and Longitudinal Laboratory TrendsYun Qiu, Shixian Hu, Kang Chao, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 16, 2025
Comparative Effectiveness of Infliximab vs Ustekinumab for Endoscopic and Transmural Remission in Biologic Naïve Crohn's DiseaseZicheng Huang, Na Diao, Qin Guo, et al.
Cardio-Oncology (London, England)|March 2, 2023
The association of preoperative high-sensitivity cardiac troponin i and long-term outcomes in colorectal cancer patients received tumor resection surgeryYitao Zhang, Zicheng Huang, Sutian Hu, et al.
Inflammatory Bowel Diseases|December 22, 2025
Risk-Stratified Biologic Efficacy in Ulcerative Colitis: A Multicenter Machine Learning StudyPingxin Zhang, Chuhan Zhang, Zishan Liu, et al.
Pageof 7

Showing results (51-60 of 68) with videos related to

Sort By:
Pageof 7
Molecular Cancer|August 29, 2014
Malignancy-associated metabolic profiling of human glioma cell lines using 1H NMR spectroscopyWei Shao, Jinping Gu, Caihua Huang, et al.
Journal of Translational Medicine|June 26, 2024
Intestinal mRNA expression profiles associated with mucosal healing in ustekinumab-treated Crohn's disease patients: bioinformatics analysis and prospective cohort validationQing Li, Zicheng Huang, Hongsheng Yang, et al.
Nutrition in Clinical Practice : Official Publication of the American Society for Parenteral and Enteral Nutrition|July 10, 2021
Twelve-week peptide-based formula therapy may be effective in inducing remission of active Crohn disease among women who are pregnant or preparing for pregnancyQingfan Yang, Jian Tang, Ni Ding, et al.
Cell Death & Disease|December 20, 2024
PI(4,5)P2 alleviates colitis by inhibiting intestinal epithelial cell pyroptosis through NNMT-mediated RBP4 m6A modificationQingfan Yang, Na Diao, Fei Ma, et al.
Journal of Nanobiotechnology|October 4, 2023
Exploring the translational potential of PLGA nanoparticles for intra-articular rapamycin delivery in osteoarthritis therapyJian-Chao Ma, Tingting Luo, Binyang Feng, et al.
Oncology Letters|October 23, 2020
Endothelial transdifferentiation of human HGC-27 gastric cancer cells <i>in vitro</i>Changxin Chen, Zhixin Hunag, Mucheng Wang, et al.
Inflammatory Bowel Diseases|August 10, 2024
Developing a Machine-Learning Prediction Model for Infliximab Response in Crohn's Disease: Integrating Clinical Characteristics and Longitudinal Laboratory TrendsYun Qiu, Shixian Hu, Kang Chao, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 16, 2025
Comparative Effectiveness of Infliximab vs Ustekinumab for Endoscopic and Transmural Remission in Biologic Naïve Crohn's DiseaseZicheng Huang, Na Diao, Qin Guo, et al.
Cardio-Oncology (London, England)|March 2, 2023
The association of preoperative high-sensitivity cardiac troponin i and long-term outcomes in colorectal cancer patients received tumor resection surgeryYitao Zhang, Zicheng Huang, Sutian Hu, et al.
Inflammatory Bowel Diseases|December 22, 2025
Risk-Stratified Biologic Efficacy in Ulcerative Colitis: A Multicenter Machine Learning StudyPingxin Zhang, Chuhan Zhang, Zishan Liu, et al.
Pageof 7